Compare

Roman DBDR Acquisition Corp. II vs Archimedes Tech SPAC Partners II Co. vs Drugs Made In America Acquisition Corp. vs Jackson Acquisition Co II

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Roman DBDR Acquisition Corp. II DRDB	Archimedes Tech SPAC Partners II Co. ATII	Drugs Made In America Acquisition Corp. DMAA	Jackson Acquisition Co II JACS
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	$7.74M	$7.99M	$5.94M	$9.12M
EPS (Diluted)	n/a	n/a	n/a	n/a
Operating cash flow	-$1.29M	-$739.0K	-$539.2K	-$427.6K
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	$183.0K	$1.36M	n/a	n/a
Total assets	$241.51M	$241.35M	$239.92M	$243.18M
Total liabilities	$1.10M	$8.19M	$7.28M	n/a
Shareholders' equity	-$778.1K	-$6.70M	-$7.26M	$220.8K
Return on year-end equity	n/a	n/a	n/a	n/m
Shares outstanding	n/a	6.59M	10.72M	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Roman DBDR Acquisition Corp. II	Archimedes Tech SPAC Partners II Co.	Drugs Made In America Acquisition Corp.	Jackson Acquisition Co II
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a